110 related articles for article (PubMed ID: 16735800)
1. Inhibition of rat renal fibroblast proliferation by halofuginone.
Haran N; Leschinski L; Pines M; Rapoport J
Nephron Exp Nephrol; 2006; 104(1):e35-40. PubMed ID: 16735800
[TBL] [Abstract][Full Text] [Related]
2. Halofuginone: an inhibitor of collagen type I synthesis.
Granot I; Halevy O; Hurwitz S; Pines M
Biochim Biophys Acta; 1993 Feb; 1156(2):107-12. PubMed ID: 8427869
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
Elkin M; Reich R; Nagler A; Aingorn E; Pines M; de-Groot N; Hochberg A; Vlodavsky I
Clin Cancer Res; 1999 Aug; 5(8):1982-8. PubMed ID: 10473075
[TBL] [Abstract][Full Text] [Related]
4. Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
McGaha TL; Phelps RG; Spiera H; Bona C
J Invest Dermatol; 2002 Mar; 118(3):461-70. PubMed ID: 11874485
[TBL] [Abstract][Full Text] [Related]
5. Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.
McGaha TL; Kodera T; Spiera H; Stan AC; Pines M; Bona CA
Arthritis Rheum; 2002 Oct; 46(10):2748-61. PubMed ID: 12384935
[TBL] [Abstract][Full Text] [Related]
6. Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
Gross DJ; Reibstein I; Weiss L; Slavin S; Dafni H; Neeman M; Pines M; Nagler A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3788-93. PubMed ID: 14506172
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone.
Nagler A; Katz A; Aingorn H; Miao HQ; Condiotti R; Genina O; Pines M; Vlodavsky I
Kidney Int; 1997 Dec; 52(6):1561-9. PubMed ID: 9407501
[TBL] [Abstract][Full Text] [Related]
8. Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes.
Gnainsky Y; Spira G; Paizi M; Bruck R; Nagler A; Abu-Amara SN; Geiger B; Genina O; Monsonego-Ornan E; Pines M
J Hepatol; 2004 Feb; 40(2):269-77. PubMed ID: 14739098
[TBL] [Abstract][Full Text] [Related]
9. Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.
Popov Y; Patsenker E; Bauer M; Niedobitek E; Schulze-Krebs A; Schuppan D
J Biol Chem; 2006 Jun; 281(22):15090-8. PubMed ID: 16489207
[TBL] [Abstract][Full Text] [Related]
10. Halofuginone inhibits serum-stimulated pericardial tissue retraction in vitro.
Marchion DC; Weber PA; Lomnitski L; Duran CM; Cheung DT
Tissue Eng; 2004; 10(7-8):1076-83. PubMed ID: 15363165
[TBL] [Abstract][Full Text] [Related]
11. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone.
Granot I; Bartov I; Plavnik I; Wax E; Hurwitz S; Pines M
Poult Sci; 1991 Jul; 70(7):1559-63. PubMed ID: 1886867
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone.
Halevy O; Nagler A; Levi-Schaffer F; Genina O; Pines M
Biochem Pharmacol; 1996 Oct; 52(7):1057-63. PubMed ID: 8831725
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
14. [Role of AcSDKP on collagen synthesis and degradation in cultured rat cardiac fibroblast].
Yang F; Zhu XL; Wang LP; Song XD; Wang RM; Li ZG; Luo L; Hu WM; Ma WD; Pei X; Zhang LJ; Li QJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):843-6. PubMed ID: 17217698
[TBL] [Abstract][Full Text] [Related]
15. Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Taras D; Blanc JF; Rullier A; Dugot-Senant N; Laurendeau I; Bièche I; Pines M; Rosenbaum J
Neoplasia; 2006 Apr; 8(4):312-8. PubMed ID: 16756723
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone.
Nagler A; Ohana M; Shibolet O; Shapira MY; Alper R; Vlodavsky I; Pines M; Ilan Y
Eur J Cancer; 2004 Jun; 40(9):1397-403. PubMed ID: 15177499
[TBL] [Abstract][Full Text] [Related]
17. Halofuginone inhibits neointimal formation of cultured rat aorta in a concentration-dependent fashion in vitro.
Liu K; Sekine S; Goto Y; Iijima K; Yamagishi I; Kondon K; Matsukawa M; Abe T
Heart Vessels; 1998; 13(1):18-23. PubMed ID: 9923561
[TBL] [Abstract][Full Text] [Related]
18. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha.
Sasaki M; Kashima M; Ito T; Watanabe A; Izumiyama N; Sano M; Kagaya M; Shioya T; Miura M
Mediators Inflamm; 2000; 9(3-4):155-60. PubMed ID: 11132772
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
Elkin M; Miao HQ; Nagler A; Aingorn E; Reich R; Hemo I; Dou HL; Pines M; Vlodavsky I
FASEB J; 2000 Dec; 14(15):2477-85. PubMed ID: 11099465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
